Inhibition of complement activation by a secreted Staphylococcus aureus protein

Journal of Infectious Diseases

Volumn 190, Issue 3, 2004, Pages 571-579

  Lee, Lawrence Y L ^a   Höök, Magnus ^a   Haviland, David ^b   Wetsel, Rick A ^b   Yonter, Edward O ^a   Syribeys, Peter ^c   Vernachio, John ^c   Brown, Eric L ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c Inhibitex   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BINDING PROTEIN; COMPLEMENT COMPONENT C3; EXTRACELLULAR FIBRINOGEN BINDING PROTEIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ALPHA CHAIN; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BINDING AFFINITY; COMPLEMENT ACTIVATION; COMPLEMENT FIXATION; COMPLEMENT SYSTEM; CONTROLLED STUDY; HOST; HUMAN; HUMAN CELL; IMMUNE SYSTEM; NONHUMAN; NUCLEOTIDE SEQUENCE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN STRUCTURE; STAPHYLOCOCCUS AUREUS;

BACTERIAL PROTEINS; CARRIER PROTEINS; COMPLEMENT ACTIVATION; COMPLEMENT C3; COMPLEMENT PATHWAY, ALTERNATIVE; COMPLEMENT PATHWAY, CLASSICAL; HL-60 CELLS; HUMANS; OPSONIN PROTEINS; PHAGOCYTOSIS; RECOMBINANT PROTEINS; STAPHYLOCOCCUS AUREUS; VIRULENCE FACTORS;

EID: 3242774515     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/422259     Document Type: Article

References (65)

1. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339: 520-32.
2. Kissane JM. Staphylococcal infections. In: Lack EE, ed. Pathology of infectious diseases. Vol 1. Stamford, CT: Appleton and Lange, 1997:805-16.
3. Hiramatsu K, Cui L, Kuroda M, Ito T. The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol 2001; 9:486-93.
4. Chavakis T, Hussain M, Kanse SM, et al. Staphylococcus aureus extracellular adherence protein serves as anti-inflammatory factor by inhibiting the recruitment of host leukocytes. Nat Med 2002; 8:687-93.
5. Bodén MK, Flock JI. Fibrinogen-binding protein/clumping factor from Staphylococcus aureus. Infect Immun 1989; 57:2358-63.
6. Chhatwal GS, Preissner KT, Muller-Berghaus G, Blobel H. Specific binding of the human S protein (vitronectin) to streptococci, Staphylococcus aureus, and Escherichia coli. Infect Immun 1987; 55:1878-83.
7. Foster TJ, Höök M. Surface protein adhesins of Staphylococcus aureus. Trends Microbiol 1998; 6:484-8.
8. Herrmann M, Suchard SJ, Boxer LA, Waldvogel FA, Lew PD. Thrombospondin binds to Staphylococcus aureus and promotes staphylococcal adherence to surfaces. Infect Immun 1991; 59:279-88.
9. Hudson MC, Ramp WK, Frankenburg KP. Staphylococcus aureus adhesion to bone matrix and bone-associated biomaterials. FEMS Microbiol Lett 1999; 173:279-84.
10. Jahreis A, Beckheinrich P, Haustein UF. Effects of two novel cationic staphylococcal proteins (NP-tase and p70) and enterotoxin B on IgE synthesis and interleukin-4 and interferon-γ production in patients with atopic dermatitis. Br J Dermatol 2000; 142:680-7.
11. Jahreis A, Yousif Y, Rump JA, et al. Two novel cationic staphylococcal proteins induce IL-2 secretion, proliferation and immunoglobulin synthesis in peripheral blood mononuclear cells (PBMC) of both healthy controls and patients with common variable immunodeficiency (CVID). Clin Exp Immunol 1995; 100:406-11.
12. Lee LY, Miyamoto YJ, McIntyre BW, et al. The Staphylococcus aureus Map protein is an immunomodulator that interferes with T cell-mediated responses. J Clin Invest 2002; 110:1461-71.
13. Renno T, Attinger A, Locatelli S, Bakker T, Vacheron S, MacDonald HR. Cutting edge: apoptosis of superantigen-activated T cells occurs preferentially after a discrete number of cell divisions in vivo. J Immunol 1999; 162:6312-5.
14. Wurzner R. Evasion of pathogens by avoiding recognition or eradication by complement, in part via molecular mimicry. Mol Immunol 1999; 36:249-60.
15. Lachmann PJ. Microbial subversion of the immune response. Proc Natl Acad Sci USA 2002; 99:8461-2.
16. Hornef MW, Wick MJ, Rhen M, Normark S. Bacterial strategies for overcoming host innate and adaptive immune responses. Nat Immunol 2002; 3:1033-40.
17. Prodinger WM, Wurzner R, Erdei A, Dierich MP. Complement. In: Paul WE, ed. Fundamental immunology. 4th ed. Philadelphia: Lippincott-Raven, 1999:967-95.
18. Neth O, Jack DL, Johnson M, Klein NJ, Turner MW. Enhancement of complement activation and opsonophagocytosis by complexes of mannose-binding lectin with mannose-binding lectin-associated serine protease after binding to Staphylococcus aureus. J Immunol 2002; 169:4430-6.
19. Kawasaki A, Takada H, Kotani S, et al. Activation of the human complement cascade by bacterial cell walls, peptidoglycans, water-soluble peptidoglycan components, and synthetic muramylpeptides studies on active components and structural requirements. Microbiol Immunol 1987; 31:551-69.
20. Bredius RG, Driedijk PC, Schouten MF, Weening RS, Out TA. Complement activation by polyclonal immunoglobulin G1 and G2 antibodies against Staphylococcus aureus, Haemophilus influenzae type b, and tetanus toxoid. Infect Immun 1992; 60:4838-47.
21. Verbrugh HA, Van Dijk WC, Peters R, Van Der Tol ME, Verhoef J. The role of Staphylococcus aureus cell-wall peptidoglycan, teichoic acid and protein A in the processes of complement activation and opsonization. Immunology 1979; 37:615-21.
22. Wilkinson BJ, Kim Y, Peterson PK, Quie PG, Michael AF. Activation of complement by cell surface components of Staphylococcus aureus. Infect Immun 1978; 20:388-92.
23. Sakiniene E, Bremell T, Tarkowski A. Complement depletion aggravates Staphylococcus aureus septicaemia and septic arthritis. Clin Exp Immunol 1999; 115:95-102.
24. Cunnion KM, Zhang HM, Frank MM. Availability of complement bound to Staphylococcus aureus to interact with membrane complement receptors influences efficiency of phagocytosis. Infect Immun 2003; 71: 656-62.
25. Cunnion KM, Frank MM. Complement activation influences Staphylococcus aureus adherence to endothelial cells. Infect Immun 2003; 71: 1321-7.
26. Bodén MK, Flock JI. Evidence for three different fibrinogen-binding proteins with unique properties from Staphylococcus aureus strain Newman. Microb Pathog 1992; 12:289-98.
27. Boden MK, Flock JI. Cloning and characterization of a gene for a 19 kDa fibrinogen-binding protein from Staphylococcus aureus. Mol Microbiol 1994; 12:599-606.
28. Palma M, Shannon O, Quezada HC, Berg A, Flock JI. Extracellular fibrinogen-binding protein, Efb, from Staphylococcus aureus blocks platelet aggregation due to its binding to the α-chain. J Biol Chem 2001; 276: 31691-7.
29. Heilmann C, Herrmann M, Kehrel BE, Peters G. Platelet-binding domains in 2 fibrinogen-binding proteins of Staphylococcus aureus identified by phage display. J Infect Dis 2002; 186:32-9.
30. Palma M, Nozohoor S, Schennings T, Heimdahl A, Flock JI. Lack of the extracellular 19-kilodalton fibrinogen-binding protein from Staphylococcus aureus decreases virulence in experimental wound infection. Infect Immun 1996; 64:5284-9.
31. Davis SL, Gurusiddappa S, McCrea KW, Perkins S, Höök M. SdrG, a fibrinogen-binding bacterial adhesin of the microbial surface components recognizing adhesive matrix molecules subfamily from Staphylococcus epidermidis, targets the thrombin cleavage site in the Bβ chain. J Biol Chem 2001; 276:27799-805.
32. Guo BP, Brown EL, Dorward DW, Rosenberg LC, Höök M. Decorin-binding adhesins from Borrelia burgdorferi. Mol Microbiol 1998; 30: 711-23.
33. Maniatis T, Fritsch EF, Sambrook J. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
34. Brown EL, Guo BP, O'Neal P, Höök M. Adherence of Borrelia burgdorferi: identification of critical lysine residues in DbpA required for decorin binding. J Biol Chem 1999; 274:26272-8.
35. Collard CD, Montalto MC, Reenstra WR, Buras JA, Stahl GL. Endothelial oxidative stress activates the lectin complement pathway: role of cytokeratin 1. Am J Pathol 2001; 159:1045-54.
36. Bassoe CF. Assessment of phagocyte functions by flow cytometry. In: Robinson ZD, Dean PN, Hibbs AR, Orfao A, Rabinovitch PS, Wheeless LL, eds. Current protocols in cytometry. New York: John Wiley & Sons, 2002:9.19.1-9.19.22.
37. Collins SJ, Gallo RC, Gallagher RE. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature 1977; 270:347-9.
38. Collins SJ, Ruscetti FW, Gallagher RE, Gallo RC. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc Natl Acad Sci USA 1978; 75:2458-62.
39. Guy B, Testart C, Gimenez S, et al. Comparison of polymorphonuclear cells from healthy donors and differentiated HL-60 cells as phagocytes in an opsonophagocytic assay using antigen-coated fluorescent beads. Clin Diagn Lab Immunol 2000; 7:314-7.
40. Lehmann AK, Halstensen A, Bassoe CF. Flow cytometric quantitation of human opsonin-dependent phagocytosis and oxidative burst responses to meningococcal antigens. Cytometry 1998; 33:406-13.
41. Martinez J, Pilishvili T, Barnard S, et al. Opsonophagocytosis of fluorescent polystyrene beads coupled to Neisseria meningitidis serogroup A, C, Y, or W135 polysaccharide correlates with serum bactericidal activity. Clin Diagn Lab Immunol 2002; 9:485-8.
42. 2+-dependent inhibitory site. J Biol Chem 1998; 273:6821-9.
43. Wann ER, Gurusiddappa S, Höök M. The fibronectin-binding MSCRAMM FnbpA of Staphylococcus aureus is a bifunctional protein that also binds to fibrinogen. J Biol Chem 2000; 275:13863-71.
44. Bodén MK, Flock JI. Cloning and characterization of a gene for a 19 kDa fibrinogen-binding protein from Staphylococcus aureus. Mol Microbiol 1994; 12:599-606.
45. Goodyear CS, Silverman GJ. Death by a B cell superantigen: in vivo VH-targeted apoptotic supraclonal B cell deletion by a staphylococcal toxin. J Exp Med 2003; 197:1125-39.
46. Joiner KA. Complement evasion by bacteria and parasites. Annu Rev Microbiol 1988; 42:201-30.
47. Cooper NR. Complement evasion strategies of microorganisms. Immunol Today 1991; 12:327-31.
48. Puentes SM, Sacks DL, da Silva RP, Joiner KA. Complement binding by two developmental stages of Leishmania major promastigotes varying in expression of a surface lipophosphoglycan. J Exp Med 1988; 167:887-902.
49. Schlesinger LS, Horwitz MA. Phagocytosis of leprosy bacilli is mediated by complement receptors CR1 and CR3 on human monocytes and complement component C3 in serum. J Clin Invest 1990; 85:1304-14.
50. Bellinger-Kawahara C, Horwitz MA. Complement component C3 fixes selectively to the major outer membrane protein (MOMP) of Legionella pneumophila and mediates phagocytosis of liposome-MOMP complexes by human monocytes. J Exp Med 1990; 172:1201-10.
51. Norris KA, Bradt B, Cooper NR, So M. Characterization of a Trypanosoma cruzi C3 binding protein with functional and genetic similarities to the human complement regulatory protein, decay-accelerating factor. J Immunol 1991; 147:2240-7.
52. Hong YQ, Ghebrehiwet B. Effect of Pseudomonas aeruginosa elastase and alkaline protease on serum complement and isolated components C1q and C3. Clin Immunol Immunopathol 1992; 62:133-8.
53. Lubinski JM, Jiang M, Hook L, et al. Herpes simplex virus type 1 evades the effects of antibody and complement in vivo. J Virol 2002; 76: 9232-41.
54. Cheng Q, Finkel D, Hostetter MK. Novel purification scheme and functions for a C3-binding prolein from Streptococcus pneumoniae. Biochemistry 2000; 39:5450-7.
55. Hall RT, Strugnell T, Wu X, Devine DV, Stiver HG. Characterization of kinetics and target proteins for binding of human complement component C3 to the surface-exposed outer membrane of Chlamydia trachomatis serovar L2. Infect Immun 1993; 61:1829-34.
56. Muller-Ortiz SL, Wanger AR, Norris SJ. Mycobacterial protein HbhA binds human complement component C3. Infect Immun 2001; 69: 7501-11.
57. Thakker M, Park JS, Carey V, Lee JC. Staphylococcus aureus serotype 5 capsular polysaccharide is antiphagocytic and enhances bacterial virulence in a murine bacteremia model. Infect Immun 1998; 66:5183-9.
58. Wilkinson BJ, Sisson SP, Kim Y, Peterson PK. Localization of the third component of complement on the cell wall of encapsulated Staphylococcus aureus M: implications for the mechanism of resistance to phagocytosis. Infect Immun 1979; 26:1159-63.
59. Cunnion KM, Lee JC, Frank MM. Capsule production and growth phase influence binding of complement to Staphylococcus aureus. Infect Immun 2001; 69:6796-803.
60. Bodén Wastfelt MK, Flock JI. Incidence of the highly conserved fib gene and expression of the fibrinogen-binding (Fib) protein among clinical isolates of Staphylococcus aureus. J Clin Microbiol 1995; 33:2347-52.
61. Peacock SJ, Moore CE, Justice A, et al. Virulent combinations of adhesin and toxin genes in natural populations of Staphylococcus aureus. Infect Immun 2002; 70:4987-96.
62. Jonsson K, McDevitt D, McGavin MH, Patti JM, Höök M. Staphylococcus aureus expresses a major histocompatibility complex class II analog. J Biol Chem 1995; 270:21457-60.
63. Horstmann RD, Sievertsen HJ, Leippe M, Fischetti VA. Role of fibrinogen in complement inhibition by streptococcal M protein. Infect Immun 1992; 60:5036-41.
64. Haggar A, Hussain M, Lonnies H, Herrmann M, Norrby-Teglund A, Flock JI. Extracellular adherence protein from Staphylococcus aureus enhances internalization into eukaryotic cells. Infect Immun 2003; 71: 2310-7.
65. Patti JM, Allen BL, McGavin MJ, Höök M. MSCRAMM-mediated adherence of microorganisms to host tissues. Annu Rev Microbiol 1994; 48:585-617.